Avacincaptad pegol: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

16 May 2024

  • curprev 10:1510:15, 16 May 2024‎ Muhammad Waleed talk contribs‎ 3,387 bytes +132‎ No edit summary
  • curprev 10:1110:11, 16 May 2024‎ Muhammad Waleed talk contribs‎ 3,255 bytes +3,255‎ Created page with "{{DrugProjectFormSinglePage |genericName=Avacincaptad Pegol |drugClass=Avacincaptad pegol is a complement C5 protein inhibitor |indication=IZERVAY is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). |adverseReactions=Common adverse reactions (≥5% of patients) include conjunctival hemorrhage, increased intraocular pressure, and endophthalmitis. |blackBoxWarningTitle=There is no black box warning listed for IZERV..."
Retrieved from "https://www.wikidoc.org/index.php/Avacincaptad_pegol"